Stock code: 301035 Stock abbreviation: Rainbow Agro Announcement No.2026-057

SHANDONG WEIFANG RAINBOW CHEMICAL CO. LTD

The Third Quarter Financial Report of 2026

The Company and all members of the Board of Directors warrant that the information disclosed is true accurate

and complete without false records misleading statements or material omissions.

1. Consolidated Balance Sheet

Prepared by: Shandong Weifang Rainbow Chemical Co. Ltd

30 September 2026

Unit: RMB

Item Closing balance Opening balance

Current assets:

Monetary funds 4133774278.78 3545858415.42

Settlement provision

Lending to banks and other financial

institutions

Financial assets held for trading 9788545.20

Derivative financial assets 4993868.53 4263716.98

Notes receivable 6461182.20 11569561.38

Accounts receivable 5250107482.30 5195696624.20

Receivables financing 2453804.14 477415.21

Pre-payments 125406224.05 100972866.06

Premium receivable

Re-insurance accounts receivable

Reserves for re-insurance contract

receivable

Other receivables 85623727.50 60549718.50

Including: interest receivable

Dividends receivable

Financial assets purchased under

resale agreement

Inventory 3536801638.57 2653810498.34

Including: Data resources

Contracted assets

Assets held for sale 9719967.70 9636456.50

Non-current assets that mature within

one year

Other current assets 502737448.91 358606869.13

Total current assets 13667868167.88 11941442141.72

Non-current assets:

Disbursed loans and advances

Debt investments

Other debt investment

Long-term receivables

Long-term equity investment 728817.42 938787.85

Other equity instrument investment

Other non-current financial assets

Investment real estate 6496786.09 7263907.46

Fixed assets 2884857768.59 2833607463.75

Construction work in progress 513631310.48 251267590.56

Productive biological assets

Oil and gas assets

Assets with rights of use 55975532.21 42571790.44

Intangible assets 350034804.45 346009832.70

Including: Data resources

Development expenditure 533619357.30 406092665.80

Including: Data resources

Goodwill 89560239.36 89560239.36

Long-term deferred expenses 20272134.40 26098818.90

Deferred income tax assets 428310275.07 403051310.07

Other non-current assets 55139031.26 63663107.82

Total non-current assets 4938626056.63 4470125514.71

Total assets 18606494224.51 16411567656.43

Current liabilities:

Short-term loan 2652542925.97 1704533162.11

Borrowings from the central bank

Borrowing from banks and financial

institutions

Financial liabilities held for trading

Derivative financial liabilities 10528627.16 43957273.82

Notes payable 4846438834.11 3968470098.87

Accounts payable 1683867984.09 1377868841.20

Advance receipts

Contract liability 77450477.69 51042591.49

Financial assets sold for repurchase

Deposits and interbank deposits

received

Amount received from agency trading

of securities

Amount received from agency

underwriting of securities

Payroll payable 325538057.20 316866749.65

Taxes payable 269857911.65 206121355.82

Other payables 70860216.79 82123529.85

Including: Interests payable

Dividends payable

Charges and commissions payable

Re-insurance accounts payable

Liabilities held for sale

Non-current liabilities due within one

226708269.43 218992467.52

year

Other current liabilities 42380692.72 14798321.16

Total current liabilities 10206173996.81 7984774391.49

Non-current liabilities:

Provision for insurance contracts

Long-term loan 62466666.66 232800000.00

Bonds payable

Including: Preferred shares

Perpetual bonds

Lease liability 53745606.34 38402680.42

Long-term payables

Long-term payroll payable

Accrued liabilities 26555248.00 26945248.00

Deferred income 21327511.83 20317043.46

Deferred income tax liabilities 73191176.16 130779705.66

Other non-current liabilities

Total non-current liabilities 237286208.99 449244677.54

Total liabilities 10443460205.80 8434019069.03

Owner’s equity:

Share capital 364505266.00 280770974.00

Other equity instruments

Including: Preferred shares

Perpetual bonds

Capital reserve 2374566734.00 2470852835.25

Less: Treasury stock 82793394.34 124837079.67

Other comprehensive income -83660568.38 27594464.95

Special reserve 32368895.29 40641595.53

Surplus reserve 179435014.25 158674657.07

General risk reserve

Undistributed profit 4851538518.29 4695381997.25

Total owners' equity attributed to parent

7635960465.11 7549079444.38

company

Minority shareholder's interest 527073553.60 428469143.02

Total owner's equity 8163034018.71 7977548587.40

Total liabilities and owners equity 18606494224.51 16411567656.43

Legal Representative: Wicky Wang Chief Accountant in Charge: Xing Bingpeng Chief of Accounting Institution: Zhang Baolin

2. Consolidated income statement from the start of 2026 to the end of Q3 2026

Unit: RMB

Item Nine months ended September 30 2026 Nine months ended September 30 2025

I. Gross Operating Income 11510518545.73 10911452781.83

Including: Operating income 11510518545.73 10911452781.83

Interest income

Premium earned

Handling charges and commissions

income

II. Total Operating Costs 10343219490.10 9410987950.18

Including: Costs of business 8730029798.31 8501898847.49

Interest expenses

Handling charges and commission

expenses

Surrender value

Net payments for insurance claims

Net withdrawal of reserve for

insurance responsibility contracts

Expenditures of policy dividend

Re-insurance expense

Taxes and surcharges 48014603.71 49558778.47

Sales expenses 590693593.84 541276149.24

Management expenses 419832673.67 401415429.92

R&D expenditures 151892506.71 133772534.32

Financial expenses 402756313.86 -216933789.26

Including: Interest expenses 56170672.20 75022595.81

Interest income 45238807.50 32405171.62

Add: Other incomes 4912278.27 4654362.94

Income from investment ("-" for

-82419145.45 -16249258.28

loss)

Including: Income from

investment in associated enterprises and -209970.43 -225713.45

joint ventures

Income recognized at

termination of financial assets measured

at amortized cost

Foreign exchange gain ("-" for loss)

Net exposure hedging income ("-"

for loss)

Income from changes in fair value

34033509.75 -128100023.82

("-" for loss)

Credit impairment losses ("-" for

-90688450.19 -114676622.01

loss)

Asset impairment losses ("-" for

-10028264.20 -2428761.50

loss)

Gains from asset disposal ("-" for

539272.77 165266.75

loss)

III. Operating Profit ("-" for loss) 1023648256.58 1243829795.73

Add: Non-operating income 5940036.33 5315310.98

Less: Non-operating expenses 10807778.25 17152244.50

IV. Total Profit Before Tax (“-” for total

1018780514.66 1231992862.21

losses)

Less: Income tax expenses 192123282.23 234569908.14

V. Net Profit ("-" for net loss) 826657232.43 997422954.07

(I) Classification by business continuity

1. Net profit from continuing

826657232.43 997422954.07

operations ("-" for net loss)

2. Net profit from discontinued

operations ("-" for net loss)

(II) Classification by ownership

1. Net profit attributable to

711420777.82 889733619.13

shareholders of the parent company

2. Profit and loss of minority

115236454.61 107689334.94

shareholders

VI. Net Amount after Tax of Other

-111255033.33 -57800314.71

Comprehensive Income

Net amount of other comprehensive

income after tax attributed to the -111255033.33 -57800314.71

owners of parent company

(I) Other comprehensive income

that cannot be reclassified into profit or

loss

1. Changes due to re-

measurement on defined benefit plan

2. Other comprehensive income

that cannot be converted into profit and

loss under the equity method

3. Changes in fair value of other

equity instrument investments

4. Changes in the fair value of the

credit risk of the enterprise

5. Other

(ii) Other comprehensive income

that will be reclassified into profit and -111255033.33 -57800314.71

loss

1. Other comprehensive income

that can be converted to profit or loss

under the equity method

2. Changes in fair value for other

investment on bonds

3. Amount of financial assets

reclassified into other comprehensive

income

4. Provision for credit

impairment of other creditor's rights

investment

5. Cash flow hedge reserve

6. Difference of foreign currency

-111255033.33 -57800314.71

financial statement translation

7. Other

Net amount of other

comprehensive income after tax

attributed to minority shareholders

VII. Total Comprehensive Income 715402199.10 939622639.36

Total comprehensive income

600165744.49 831933304.42

attributed to parent company owners

Total comprehensive income

115236454.61 107689334.94

attributed to minority shareholders

VIII. Earnings per Share:

(i) Basic earnings per share 1.96 2.46

(ii) Diluted earnings per share 1.96 2.45

Legal Representative: Wicky Wang Chief Accountant in Charge: Xing Bingpeng Chief of Accounting Institution: Zhang Baolin

3. Consolidated cash flow statement from the start of 2026 to the end of Q3 2026

Unit: RMB

Item Nine months ended September 30 2026 Nine months ended September 30 2025

I. Cash Flows Generated from Operating

Activities:

Cash received from sales of goods and

11522832099.95 10927180152.79

services

Net increase in deposit from

customers and interbank

Net increase in borrowing from

central bank

Net increase in borrowings from other

financial institutions

Cash receipts from premiums under

direct insurance contracts

Net cash receipts from re-insurance

business

Net cash receipts from policyholders'

deposits and investments

Cash receipts from interest handling

fees and commissions

Net increase in capital borrowed from

banks and other financial institutions

Net increase in repurchase business

capital

Net cash received from securities

trading brokerage

Cash receipts from tax refunds 734305981.10 682472830.95

Cash received relating to other

56091122.10 45534591.11

operating activities

Subtotal of cash inflow in business

12313229203.15 11655187574.85

activities

Cash payments for goods acquired

9564071085.27 8193069943.45

and services received

Net increase in customer loans and

advances

Net increase in deposits in central

bank and interbank

Cash payments for original insurance

contract claims

Net increase in lending funds from

banks and other financial institutions

Cash payments for interest fee and

commission

Cash payments for insurance

policyholder dividends

Cash payments to employees and on

906626081.56 749380596.43

behalf of employees

Cash payments for taxes 309438433.57 234736883.10

Other cash payments relating to

763277417.84 737685814.09

operating activities

Subtotal of cash outflow in business

11543413018.24 9914873237.07

activities

Net cash flow from operating activities 769816184.91 1740314337.78

II. Cash Flows from Investing Activities:

Cash receipts from investment

withdrawal

Cash receipts from return on

investments

Net cash receipts from disposals of

fixed assets intangible assets and other 11390792.60

long- term assets

Net cash receipts from disposal of

subsidiary or any other business unit

Other cash receipts relating to 34638377.54 15056546.36

investing activities

Subtotal of cash inflow in investment

46029170.14 15056546.36

activities

Cash payments to acquire or

construct fixed assets intangible assets 455262541.81 551490687.04

and other long-term assets

Cash payments for investment

Net increase in pledged loans

Net cash payments to acquire

subsidiary and other business units

Other cash payments relating to

116847552.58 32427588.54

investment activities

Subtotal of cash outflow in investment

572110094.39 583918275.58

activities

Net cash flow in investment activities -526080924.25 -568861729.22

III. Cash Flows from Financing Activities:

Cash received from capital

contributions

Including: Cash received from

investment of minority shareholder

from subsidiary

Cash receipts from borrowings 2468118080.55 1857928465.40

Other cash receipts relating to

financing activities

Subtotal of cash inflow in financing

2468118080.55 1857928465.40

activities

Cash repayments of borrowings 1825775003.67 2143533066.02

Cash payments for distribution of

dividends profits or cash payments 592189217.65 303857067.85

for interest expenses

Including: Dividends and profits

paid to minority shareholders by

subsidiaries

Other cash paid related to financing

activities

Subtotal of cash outflow in financing

2417964221.32 2447390133.87

activities

Net cash flow from financing activities 50153859.23 -589461668.47

IV. Effect of Exchange Rate Changes on

-44788577.34 40593995.74

Cash and Cash Equivalents

V. Net Increase in Cash and Cash

249100542.55 622584935.83

Equivalents

Add: Beginning balance of cash and

1455356930.03 1288636135.42

cash equivalents

VI. Closing Balance of Cash and Cash

1704457472.58 1911221071.25

Equivalents

Should there be any difference in the interpretation of the contents the Chinese version of the Third Quarter Financial Report of

2026 shall prevail.

SHANDONG WEIFANG RAINBOW CHEMICAL CO.LTD

Board of Directors

October 28 2026